Medicine and Dentistry
Colorectal Cancer
100%
Protein
73%
Prognosis
49%
Biological Marker
43%
Patient
42%
Overall Survival
27%
Esophageal Adenocarcinoma
24%
Colon
20%
Primary Tumor
18%
Cohort Analysis
17%
Lymph Node Metastasis
16%
Hazard Ratio
15%
Proportional Hazards Model
12%
Tissue Microarray
12%
Programmed Death-Ligand 1
12%
Tumor Infiltrating Lymphocyte
12%
Ligand
12%
Adenocarcinoma
12%
Bladder Cancer
12%
Neoadjuvant Chemotherapy
12%
Prognostic Factor
11%
Rectum
10%
Body Mass Index
10%
Regression Analysis
9%
Adjuvant Chemotherapy
6%
Waist-Hip Ratio
5%
Chemotherapy
5%
Woman
5%
Man
5%
Cancer Cell
5%
Biochemistry, Genetics and Molecular Biology
Protein
73%
PD-L1
24%
KRAS
13%
Immunology and Microbiology
Programmed Death-Ligand 1
24%
Prognostic Biomarker
12%
Immunocompetent Cell
12%
Waist Hip Ratio
10%
Cell Adhesion
8%
Cell Marker
8%
Real-Time Polymerase Chain Reaction
5%
Immune Landscape
5%
